Navalign LLC’s Colgate-Palmolive CL Stock Holding History

Navalign LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-149	Closed	-$11.7K	–	182
2025 Q4	$11.7K	Buy	+149	New	+$11.7K	﹤0.01%	318

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Navalign LLC's CL Position: Q1 2026 in Review

Navalign LLC sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 149 shares — an estimated $11.7K sold.

Navalign LLC first reported a position in CL in Q4 2025 and held it in 1 quarter. The position peaked at $11.7K in Q4 2025. 1,953 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Navalign LLC reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 149 Colgate-Palmolive shares in Q1 2026, an estimated $11.7K.
Navalign LLC first reported a position in Colgate-Palmolive in Q4 2025 and held it in 1 quarter.
Navalign LLC's Colgate-Palmolive position peaked at $11.7K in Q4 2025.
1,953 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.